Episode 11: In this podcast, Jaspal Singh, MD, interviews Saadia A. Faiz, MD, and Neha Dangayach, MD, MSCR, on the effective use of social media in pulmonary and critical care medicine, including what clinicians can use social media for, how it can help improve patient care, how much to share, the benefits and risks, and ways to avoid burnout using social media.
In this COVID-19 roundup, we discuss the latest booster recommendations by the CDC, recent recommendations on the first antiviral COVID-19 pill, and the odds of COVID-19 infection following 2 and 3 doses of an mRNA vaccine.
A 64-year-old woman presented to our clinic with constant pain in her left hand that had been worsening over the past 3 months. She described the pain as sharp and has experienced stiffness with the inability to fully extend her fingers. She also reported associated hand and finger swelling.
The guideline panel published 8 clinical practice recommendations for patients, clinicians, policy makers, and researchers.
The Infectious Diseases Society of America has published treatment guidance on 3 of the most common drug-resistant pathogens: AmpC b-lactamase producing Enterobacterales, Carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia.
The drug is approved as a diagnostic tool to help identify cancerous lesions during surgery, which is normally difficult to detect. The drug is administered intravenously prior to surgery.
The medication is indicated for adults and children aged 12 years or older weighing at least 35 kg, and few adverse effects were reported in clinical trials.
It is the first and only cell-based quadrivalent influenza vaccine in the United States and is an alternative for individuals allergic to the egg-based vaccines.
The low-dose tablet is a new formulation of an existing HIV medication already approved for adults.
Do you know the prevalence of uterine fibroids in the United States? Test your knowledge with our latest pop quiz to find out!